Abstract
INVITRO EVALUATION OF GEMCITABINE AND ITS DERIVATIVE (GEMCITABINE MONOPHOSPHATE) FOR THE TREATMENT OF PANCREATIC CANCER
Shaik Nazma Sultana*, Dr. Syed Ahmed Hussain, Sara Umm E. Hani, Farahanaaz Begum and Juveria Gaffar
ABSTRACT
This research paper explores the cellular effects of Gemcitabine Monophosphate on cellular viability, tubulogenesis, and protein expression levels. The study employed various assays, including the MTT assay, Tubulogenesis assay, Indirect Immunofluorescence assay, and Western Blot analysis. The research involved four treatment groups: Group 1 (normal), Group 2 (Control cell line), Group 3 (Standard GEMCITABINE), and Group 4 (Gemcitabine Monophosphate). The results indicate that Gemcitabine Monophosphate significantly affects cellular viability, tubulogenesis, and protein expression levels when compared to standard GEMCITABINE treatment, highlighting the need for further research to understand its potential implications.
[Full Text Article] [Download Certificate]WJPLS CITATION
All | Since 2019 | |
Citation | 422 | 322 |
h-index | 9 | 7 |
i10-index | 4 | 2 |
INDEXING
NEWS & UPDATION
BEST ARTICLE AWARDS
World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Article of current issue
Download Article : Click here